Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2001

View Archived Issues

Amgen advances antibody into clinical trials, triggering milestone payment to Abgenix

SangStat enters into collaborations geared toward next-generation RDP-58 molecules

Licensing opportunity from NIH: immunostimulant LL-37

Vibrio cholerae O139 conjugate vaccines available for licensing from NIH

3M seeks additional FDA approval of QVAR

New Photofrin indication filed with Canadian authorities

Positive long-term survival and safety data reported for OvaRex

Idec submits additional information for Zevalin BLA

Macrophage aP2 as a target for therapy of atherosclerosis

Neutrophil elastase inhibitor prevents cancer metastasis in animal model

Direct factor Xa inhibitor DX-9065a shows promise for thrombosis and restenosis

Good safety, dose-proportional pharmacokinetics seen in early clinical trial of rPSGL-Ig

Ceprotin has beneficial therapeutic and prophylactic effects in protein C deficiency

FDA issues approvable letter for Natrecor

Identification, structure and biological activity of new glycoprotein trafficking inhibitor

Exelixis delivers cancer antibody targets to PDL for further development

Rational design of mesangial cell proliferation inhibitors

Microcide and Naeja to codevelop novel antifungal agents

Lexicon/Coelacanth merger complete

Excellent antibacterial profile demonstrated for HMR-3562 against enterococci

Olamufloxacin has high activity in murine models of systemic infections and UTIs

CDK-inhibitory quinazolines particularly useful for proliferative cardiovascular disorders

Cor's new anticoagulants presented in patent literature

Antiinflammatory compounds reported by Boehringer Ingelheim

Nontoxic MMP inhibitor from Pharmacia with antitumor activity

CXC chemokine inhibitors under development by French lab

Potent and selective antagonists of neuropeptide Y5 receptors identified at Shionogi

Enzo Biochem cleared to begin trial of immune regulation medicine for Crohn's disease

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...